The sensitivity and specificity of urinary L-FABP for diagnosis of DN in type 2 diabetes in our study (98.1% and 90%, respectively) were higher than those for diagnosis of AKI in a meta-analysis (74.5% and 77.6%, respectively). The gene discussed is FABP1; the disease is type 2 diabetes mellitus.